Key points are not available for this paper at this time.
Abstract: One common cancer among women is breast cancer. Chemotherapy, radiation therapy, and surgery have historically been used as breast cancer treatments. Thanks to recent technological advancements, we have been able to progressively comprehend the complexity and heterogeneity of diseases, which has led to the development of more effective treatments for many conditions. Working with variably shaped nanoparticles, nanotechnology has recently enabled us to work on tumor targeting and drug delivery, and it has undoubtedly helped to reduce the spread and death of breast cancer. The efficacy of treatment for breast cancer can be increased by a variety of target therapies made possible by nanotechnology. The current review discusses the advantages and disadvantages of nanotechnology-based therapy for breast cancer while also highlighting the disease's current state. The article will provide an overview of the current strategy available for better treatment of breast cancer and aid in understanding the various drug delivery systems designed to provide effective treatment for the disease. By utilizing cutting-edge technologies and early screening, breast cancer fatalities can be decreased. Drug delivery methods based on nano carriers enable medication to reach the target site at the ideal concentration with the least amount of harmful side effects.
Prabha et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: